Table 2 Demographic characteristics of trivalent influenza vaccine (TIV) completed, partial and non-vaccinated households during the three consecutive years of influenza seasons (2008–2011)

3.28

3.45

4.2

7.46

3.84

3.76

7.50

4.12

(3.00,3.58)

(3.18,3.72)

(3.83,4.64)

(6.51,8.40)

(3.35,4.34)

(3.15,4.36)

(6.06,8.94)

(3.70,4.54)

28(0.47)

22(0.38)

34(0.30)

15(0.43)

29(0.51)

*

20(0.49)

9(0.45)

35(0.30)

*

31(0.53)

43(0.62)

80(0.70)

20(0.57)

28(0.49)

21(0.51)

11(0.55)

80(0.70)

31(0.53)

34(0.52)

71(0.52)

33(0.47)

31(0.48)

19(0.41)

21(0.49)

75(0.54)

28(0.47)

31(0.48)

66(0.48)

37(0.53)

33(0.52)

27(0.59)

22(0.51)

65(0.46)

9.24

8.00

*

9.39

9.20

9.11

10.80

9.65

9.66

*

(8.83,9.64)

(7.64,8.36)

(9.10,9.68)

(8.75,9.65)

(8.76,9.45)

(10.24,11.37)

(9.04,10.26)

(9.39,9.94)

60(0.44)

63(0.40)

152(0.44)

78(0.44)

55(0.40)

40(0.37)

45(0.42)

142(0.44)

75(0.56)

96(0.60)

192(0.56)

100(0.56)

84(0.60)

68(0.63)

61(0.58)

181(0.56)

37(0.27)

43(0.27)

80(0.23)

45(0.25)

15(0.11)

*

31(0.29)

32(0.30)

74(0.23)

98(0.73)

116(0.73)

264(0.77)

133(0.75)

124(0.89)

77(0.71)

74(0.70)

249(0.77)

34.35

33.51

36.84

36.19

40.22

35.47

31.81

36.49

(31.46,37.24)

(30.82,36.20)

(34.91,38.77)

(33.51,38.87)

(37.58,42.85)

(31.79,39.16)

(28.63,34.99)

(34.55,38.43)

9(0.07)

29(0.18)

7(0.02)

21(0.12)

23(0.17)

*

16(0.15)

18(0.17)

68(0.21)

126(0.93)

130(0.82)

337(0.98)

157(0.88)

116(0.83)

92(0.85)

88(0.83)

255(0.79)